MetLife Investment Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $369K | Sell |
|
|||||
|
2025
Q2 | $545K | Buy |
|
|||||
|
2025
Q1 | $227K | Buy |
|
|||||
|
2024
Q4 | $198K | Buy |
|
|||||
|
2024
Q3 | $89.8K | Buy |
|
|||||
|
2024
Q2 | $55.2K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $61.2K | Buy |
|
|||||
|
2021
Q4 | $69.6K | Sell |
|
|||||
|
2021
Q3 | $184K | Buy |
|
|||||
|
2021
Q2 | $123K | Sell |
|
|||||
|
2021
Q1 | $206K | Buy |
|
|||||
|
2020
Q4 | $89.9K | Buy |
|
|||||
|
2020
Q3 | $71K | Sell |
|
|||||
|
2020
Q2 | $790K | Buy |
|
|||||
|
2020
Q1 | $396K | Buy |
|
|||||
|
2019
Q4 | $263K | Sell |
|
|||||
|
2019
Q3 | $225K | Hold |
|
|||||
|
2019
Q2 | $277K | Buy |
|
|||||
|
2019
Q1 | $333K | Hold |
|
|||||
|
2018
Q4 | $225K | Buy |
|
|||||
|
2018
Q3 | $189K | Hold |
|
|||||
|
2018
Q2 | $214K | Hold |
|
|||||
|
2018
Q1 | $204K | Hold |
|
|||||
|
2017
Q4 | $319K | Buy |
|